NCT06305754 2026-03-13
MK-2870-009
Merck Sharp & Dohme LLC
Phase 3 Recruiting
Clinical Trials
12 trialsNCT06824467 2026-03-13
TroFuse-022
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT06043323 2026-03-12
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT05896228 2026-03-11
Iber-KDd
University of Miami
Phase 2 Recruiting
NCT06788912 2026-03-10
MK-3475-01E
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT06992427 2026-03-04
HOPE
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT05319730 2026-03-02
MK-3475-06B
Merck Sharp & Dohme LLC
Phase 1/2 Recruiting
NCT07101445 2026-02-10
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
Emory University
Phase 4 Recruiting
NCT07200544 2025-12-15
Meloxicam in Mohs Micrographic Surgery
University of Oklahoma
Phase 4 Recruiting
NCT05088876 2025-11-26
ParOP
Insel Gruppe AG, University Hospital Bern
Phase 4 Recruiting
NCT03823534 2025-10-15
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
St. Louis University
Phase 3 Recruiting
NCT05842044 2025-09-05
No-PAIN
University of Miami
Phase 2 Recruiting